Chloroquine induces the expression of inducible nitric oxide synthase in C6 glioma cells

Tso Hsiao Chen, Po Chiao Chang, Mon Chiu Chang, Yuan Fong Lin, Horng Mo Lee

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Chloroquine, a well-known lysosomotropic agent, has long been used for the treatment of malaria and rheumatologic disorders. However, therapeutic doses of chloroquine are known to cause behavioral side effects. In the present study, we investigated whether chloroquine stimulates inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) synthesis in C6 glioma cells. Chloroquine caused dose-dependent increase in iNOS protein expression and NO production in C6 glioma cells. A tyrosine kinase inhibitor (genistein), a protein kinase C (PKC) inhibitor (Ro 31-8220), and a p38 mitogen-activated protein kinase (MAPK) inhibitor (SB 203580) all respectively suppressed chloroquine-induced iNOS expression and NO release from C6 glioma cells. Chloroquine activates p38 MAPK and stimulates PKC-α and -δ translocation from the cytosol to the membrane in C6 glioma cells. Chloroquine-stimulated p38 MAPK activation was blocked by genistein (20 μM), Ro 31-8220 (3 μM), and SB 203580 (10 μM). Incubation of lipopolysaccharide (LPS)-stimulated cells with chloroquine at non-toxic concentrations (10-100 μM) for 48 h increased iNOS expression, and led to a significant loss of adherent cells. Induction of DNA fragmentation in floating cells indicated that the C6 glioma cells were undergoing apoptosis. Taken together, our data suggest that chloroquine may activate tyrosine kinase and/or PKC to induce p38 MAPK activation, which in turn induces iNOS expression and NO production.

Original languageEnglish
Pages (from-to)329-336
Number of pages8
JournalPharmacological Research
Volume51
Issue number4
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Chloroquine
Nitric Oxide Synthase Type II
Glioma
p38 Mitogen-Activated Protein Kinases
Nitric Oxide
Protein Kinase C
Genistein
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Protein C Inhibitor
DNA Fragmentation
Cytosol
Malaria
Lipopolysaccharides
Apoptosis
Membranes

Keywords

  • C6 glioma cells
  • Chloroquine
  • iNOS
  • p38 MAPK

ASJC Scopus subject areas

  • Pharmacology

Cite this

Chloroquine induces the expression of inducible nitric oxide synthase in C6 glioma cells. / Chen, Tso Hsiao; Chang, Po Chiao; Chang, Mon Chiu; Lin, Yuan Fong; Lee, Horng Mo.

In: Pharmacological Research, Vol. 51, No. 4, 04.2005, p. 329-336.

Research output: Contribution to journalArticle

@article{7dda53307c264cb1b36c09128bd7aa05,
title = "Chloroquine induces the expression of inducible nitric oxide synthase in C6 glioma cells",
abstract = "Chloroquine, a well-known lysosomotropic agent, has long been used for the treatment of malaria and rheumatologic disorders. However, therapeutic doses of chloroquine are known to cause behavioral side effects. In the present study, we investigated whether chloroquine stimulates inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) synthesis in C6 glioma cells. Chloroquine caused dose-dependent increase in iNOS protein expression and NO production in C6 glioma cells. A tyrosine kinase inhibitor (genistein), a protein kinase C (PKC) inhibitor (Ro 31-8220), and a p38 mitogen-activated protein kinase (MAPK) inhibitor (SB 203580) all respectively suppressed chloroquine-induced iNOS expression and NO release from C6 glioma cells. Chloroquine activates p38 MAPK and stimulates PKC-α and -δ translocation from the cytosol to the membrane in C6 glioma cells. Chloroquine-stimulated p38 MAPK activation was blocked by genistein (20 μM), Ro 31-8220 (3 μM), and SB 203580 (10 μM). Incubation of lipopolysaccharide (LPS)-stimulated cells with chloroquine at non-toxic concentrations (10-100 μM) for 48 h increased iNOS expression, and led to a significant loss of adherent cells. Induction of DNA fragmentation in floating cells indicated that the C6 glioma cells were undergoing apoptosis. Taken together, our data suggest that chloroquine may activate tyrosine kinase and/or PKC to induce p38 MAPK activation, which in turn induces iNOS expression and NO production.",
keywords = "C6 glioma cells, Chloroquine, iNOS, p38 MAPK",
author = "Chen, {Tso Hsiao} and Chang, {Po Chiao} and Chang, {Mon Chiu} and Lin, {Yuan Fong} and Lee, {Horng Mo}",
year = "2005",
month = "4",
doi = "10.1016/j.phrs.2004.10.004",
language = "English",
volume = "51",
pages = "329--336",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Chloroquine induces the expression of inducible nitric oxide synthase in C6 glioma cells

AU - Chen, Tso Hsiao

AU - Chang, Po Chiao

AU - Chang, Mon Chiu

AU - Lin, Yuan Fong

AU - Lee, Horng Mo

PY - 2005/4

Y1 - 2005/4

N2 - Chloroquine, a well-known lysosomotropic agent, has long been used for the treatment of malaria and rheumatologic disorders. However, therapeutic doses of chloroquine are known to cause behavioral side effects. In the present study, we investigated whether chloroquine stimulates inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) synthesis in C6 glioma cells. Chloroquine caused dose-dependent increase in iNOS protein expression and NO production in C6 glioma cells. A tyrosine kinase inhibitor (genistein), a protein kinase C (PKC) inhibitor (Ro 31-8220), and a p38 mitogen-activated protein kinase (MAPK) inhibitor (SB 203580) all respectively suppressed chloroquine-induced iNOS expression and NO release from C6 glioma cells. Chloroquine activates p38 MAPK and stimulates PKC-α and -δ translocation from the cytosol to the membrane in C6 glioma cells. Chloroquine-stimulated p38 MAPK activation was blocked by genistein (20 μM), Ro 31-8220 (3 μM), and SB 203580 (10 μM). Incubation of lipopolysaccharide (LPS)-stimulated cells with chloroquine at non-toxic concentrations (10-100 μM) for 48 h increased iNOS expression, and led to a significant loss of adherent cells. Induction of DNA fragmentation in floating cells indicated that the C6 glioma cells were undergoing apoptosis. Taken together, our data suggest that chloroquine may activate tyrosine kinase and/or PKC to induce p38 MAPK activation, which in turn induces iNOS expression and NO production.

AB - Chloroquine, a well-known lysosomotropic agent, has long been used for the treatment of malaria and rheumatologic disorders. However, therapeutic doses of chloroquine are known to cause behavioral side effects. In the present study, we investigated whether chloroquine stimulates inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) synthesis in C6 glioma cells. Chloroquine caused dose-dependent increase in iNOS protein expression and NO production in C6 glioma cells. A tyrosine kinase inhibitor (genistein), a protein kinase C (PKC) inhibitor (Ro 31-8220), and a p38 mitogen-activated protein kinase (MAPK) inhibitor (SB 203580) all respectively suppressed chloroquine-induced iNOS expression and NO release from C6 glioma cells. Chloroquine activates p38 MAPK and stimulates PKC-α and -δ translocation from the cytosol to the membrane in C6 glioma cells. Chloroquine-stimulated p38 MAPK activation was blocked by genistein (20 μM), Ro 31-8220 (3 μM), and SB 203580 (10 μM). Incubation of lipopolysaccharide (LPS)-stimulated cells with chloroquine at non-toxic concentrations (10-100 μM) for 48 h increased iNOS expression, and led to a significant loss of adherent cells. Induction of DNA fragmentation in floating cells indicated that the C6 glioma cells were undergoing apoptosis. Taken together, our data suggest that chloroquine may activate tyrosine kinase and/or PKC to induce p38 MAPK activation, which in turn induces iNOS expression and NO production.

KW - C6 glioma cells

KW - Chloroquine

KW - iNOS

KW - p38 MAPK

UR - http://www.scopus.com/inward/record.url?scp=15944365872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15944365872&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2004.10.004

DO - 10.1016/j.phrs.2004.10.004

M3 - Article

C2 - 15683746

AN - SCOPUS:15944365872

VL - 51

SP - 329

EP - 336

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 4

ER -